Evidence map›Paper›PMID 30498000›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2018

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Sankar D Navaneethan, Julia M Akeroyd, David Ramsey, Sarah T Ahmed, Shiva Raj Mishra, Laura A Petersen, Paul Muntner, Christie Ballantyne, Wolfgang C Winkelmayer, Venkat Ramanathan and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Epidemiology of Diabetic Kidney Disease among US Veterans.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sankar D NavaneethanSelzman Institute for Kidney Health, Section of Nephrology.
Julia M AkeroydSection of Health Services Research, and.
David RamseyCenter for Longitudinal and Lifecourse Research, Faculty of Medicine, University of Queensland, Brisbane, Australia; and.
Sarah T AhmedHealth Policy, Quality and Informatics Program, Health Services Research and Development Center for Innovations, and.
Shiva Raj MishraCenter for Longitudinal and Lifecourse Research, Faculty of Medicine, University of Queensland, Brisbane, Australia; and.
Laura A PetersenHealth Policy, Quality and Informatics Program, Health Services Research and Development Center for Innovations, and.
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
Christie BallantyneSection of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Wolfgang C WinkelmayerSelzman Institute for Kidney Health, Section of Nephrology.
Venkat RamanathanSelzman Institute for Kidney Health, Section of Nephrology.
Salim S ViraniSection of Health Services Research, and.

Funding

HSRD VA I01 HX003868
6 · The paper itself

Abstract

BACKGROUND AND

objectivesFacility-level variation has been reported among veterans receiving care for various diseases. We studied the frequency and facility-level variations of guideline-recommended practices in patients with diabetes and CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with diabetes and concomitant CKD (eGFR 15-59 ml/min per 1.73 m

resultsAmong those with eGFR 30-59 ml/min per 1.73 m

conclusionsAmong patients with diabetes and CKD, at facility-level, ordering of laboratory tests, and scheduling of nephrology referrals in eligible patients remains suboptimal, with substantial variations across facilities.

Indexed as

AdolescentAdultAgedDelivery of Health CareDiabetes MellitusDiabetic NephropathiesFemaleGlomerular Filtration RateGuideline AdherenceHealth FacilitiesHumansMaleMiddle AgedRenal Insufficiency, ChronicUnited StatesVeterans HealthAlbuminsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonistsblood pressurechronic kidney disease, practice patterns, nephrology visits, variations, albuminuria, glomerular filtration rateConfidence Intervalscreatininediabetes mellitusHemoglobinsHydroxymethylglutaryl-CoA Reductase InhibitorsKidney Function TestsOutcome Assessment (Health Care)Referral and ConsultationRenal Insufficiency, ChronicVeterans

Identifiers

PMID30498000
PMCPMC6302320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.